With Market Size Valued at $6.5 Billion by 2026, it`s a Healthy

SAN FRANCISCO, Jan. 18, 2022 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled “Throat Lozenges – Global Market Trajectory & Analytics”. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
Edition: 5; Released: January 2022
Executive Pool: 866
Companies: 87 – Players covered include Bliss GVS Pharma Ltd.; GlaxoSmithKline plc; Honibe (Island Abbey Food Science Ltd.).; Prestige Consumer Healthcare, Inc.; Procter & Gamble Company; Reckitt Benckiser Group Plc; Ricola AG; Sanofi S.A; Thornton & Ross Ltd.; Wm. Wrigley Jr. Company and Others.
Coverage: All major geographies and key segments
Segments: Type (Hard Candy, Soft, Compressed); Indication (Sore Throat, Cough & Cold, Throat Diseases)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Complimentary Project Preview – This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Throat Lozenges Market to Reach US$6.5 Billion by the Year 2026
Throat lozenge, also referred to as cachou cough drop, cough sweet or troche, constitutes a medicated tablet that dissolves in the mouth, slowly, and stops cough. The small tablet works by soothing and lubricating irritated tissues of the throat and thus pacifying a strep or sore throat caused by common cold or influenza. Growth in the global market is driven by the growing incidence of sore throat, cough and cold. Cold & cough are common diseases worldwide and sore throat lozenges are used as first-line treatments, which is also a prominent market growth promoting factor. Another major factor driving growth is the rise in geriatric population that is at the higher risk of contracting infections because of their lower immunity levels. Furthermore, Increasing HIV penetration is also a major market growth promoting factor because HIV patients are at greater risk of developing infections. Decreased immunity in people due to dietary habit changes and lifestyles becoming more sedentary…